Back to Trades
Mandel-Brehm Josh
Chief Executive OfficerDirectorCIK 0001927058
Profile
- Filings
- 3
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Mandel-Brehm Josh, Chief Executive Officer, Director, has filed 3 SEC reports (2025–2026), all concentrated in Camp4 Therapeutics Corp (CAMP), totaling $5.2M in disclosed volume. Weighing $10.0K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $10.0K in Camp4 Therapeutics Corp. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Apr 3 | CAMP Camp4 Therapeutics Corp | Mandel-Brehm Josh | Chief Executive Officer, Director | Award | $2.6M |
| Dec 22 | CAMP Camp4 Therapeutics Corp | Mandel-Brehm Josh | Chief Executive Officer, Director | Award | $2.6M |
| Sep 11 | CAMP Camp4 Therapeutics Corp | Mandel-Brehm Josh | Chief Executive Officer, Director | Buy | $10.0K |
3 filings